| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| nice dostarlimab endometrial cancer | 0.95 | 0.8 | 5622 | 84 | 35 |
| nice | 1.39 | 0.6 | 6362 | 59 | 4 |
| dostarlimab | 1.84 | 0.6 | 970 | 77 | 11 |
| endometrial | 1.7 | 0.1 | 8413 | 13 | 11 |
| cancer | 0.43 | 0.3 | 8302 | 33 | 6 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nice dostarlimab endometrial cancer | 0.98 | 1 | 7927 | 61 |
| dostarlimab endometrial cancer nejm | 0.19 | 0.5 | 4270 | 94 |
| dostarlimab for endometrial cancer | 0.35 | 0.1 | 8346 | 51 |
| nice pembrolizumab endometrial cancer | 1.52 | 0.7 | 7958 | 40 |
| dostarlimab endometrial cancer fda | 1.35 | 0.7 | 5901 | 95 |
| nice guidance endometrial cancer | 0.89 | 0.4 | 3036 | 32 |
| dostarlimab chemotherapy endometrial cancer | 1.24 | 0.3 | 9217 | 68 |
| endometrial cancer guidelines nice | 0.21 | 0.3 | 1785 | 7 |
| dostarlimab endometrial cancer fda approval | 0.98 | 0.5 | 9228 | 9 |
| endometrial cancer nice cks | 0.41 | 0.9 | 3248 | 63 |
| dostarlimab for breast cancer | 1.13 | 0.6 | 4381 | 96 |
| nice pembrolizumab lenvatinib endometrial | 1.03 | 0.8 | 8735 | 69 |
| dostarlimab breast cancer treatment | 0.63 | 0.1 | 4394 | 99 |
| new treatment for endometrial cancer | 1.81 | 0.8 | 3410 | 61 |
| nice guidelines endometriosis uk | 1.08 | 0.8 | 1472 | 79 |
| endometrial cancer treatment nhs | 1.71 | 0.2 | 1132 | 97 |
| nice guidelines on endometriosis | 1.13 | 0.8 | 4664 | 1 |
